Cannabis Law Report

JANUARY 13, 2022

Happy 2022! In The Weeds welcomes the new year, as well as a number of new cannabis laws and policies taking effect around the country in 2022. 1, Louisiana’s medical cannabis program allows patients to access smokable whole-plant flower marijuana. McGuireWoods LLP. Newsworthy Highlights. Montana: As of Jan. The 1st U.S.

Dispensary 52

Dispensary Law Concentrates Patients 52

Cannabis Law Report

APRIL 14, 2022

Accordingly, state pesticide programs have tried to provide some clarity to fill the gap left by EPA. pursuant to Drug Enforcement Agency (DEA) or state-level programs). Grow operations generate agricultural waste that must be managed and disposed of as a regulated or scheduled substance (e.g., million cars on the road.

Environment 52

Environment Agriculture Compliance Compliance 52

Cannabis Law Report

MAY 29, 2022

8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. DEA and the Controlled Substances Act. In addition to the arduous FDA approval process, potential psychedelic therapies would also require complying with requirements from the Drug Enforcement Administration (DEA). 2] David E.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Canna Law Blog

JULY 26, 2023

Before the 2018 Farm Bill, only a few states ran limited “research” pilot programs for hemp. But, take a look: The USDA 2022 National Hemp Report , at page 1, indicates that all industrial hemp “in the open” totaled 28,314 acres. This ties directly into marijuana policy, the Controlled Substances Act, and what DEA is thinking about.

Hemp 81

Hemp DEA THC Policy 81

Cannabis Law Report

MARCH 3, 2022

— Cannabis & Tech Today (@cannatechtoday) February 24, 2022. He also rejected requests to lift a federal ban on harm reduction policies like syringe exchange programs. link] #news #cannatechtoday #breaking #thc #florida #orlando #clinton #cbd #pain.

Media 52

Media CBD Events THC 52

Cannabis Law Report

JULY 28, 2022

July 28, 2022. Colorado could decriminalize the personal use and possession of certain psychedelic plants and fungi, including “magic mushrooms,” and create a Natural Medicine Access Program, according to a voter initiative on the November ballot. By Dan Flynn. Petitioners had six months to circulate signature petitions.

Legalization 52

Legalization Decriminalization Food Safety 52

Cannabis Law Report

NOVEMBER 20, 2021

Drug Enforcement Administration (DEA), the Alabama Prescription Drug Monitoring Program maintained by Alabama Department of Public Health, and the Alabama Medical Cannabis Patient Registry System maintained by the Alabama Medical Cannabis Commission. Obtaining this permit requires the physician to: complete an application.

Patients 52

Patients DEA Dispensary Conditions 52

Veriheal

SEPTEMBER 9, 2021

” This fee — which is designed to support social equity programs — is required to convert up to three medical cannabis dispensaries into dual medical-recreational facilities. The market’s projected start date is May 2022. Connecticut. Another adult-use cannabis market will transpire next year in Connecticut. New Mexico.

Legalization 109

Legalization Recreational Business Retail 109

Canna Law Blog

NOVEMBER 21, 2021

Earlier this year, we wrote about how MAPS was progressing through the Phase III study process and was targeting FDA approval in 2022 and commercialization in 2023 — if these targets are met, they would be on par with Oregon’s legal psilocybin licensing program.

Decriminalization 84

Decriminalization DEA Conditions Food 84

Cannabis Law Report

AUGUST 18, 2022

17, 2022 – PRESS RELEASE – Raising the standard for cannabis and hemp testing, ACS Laboratory , the largest hemp and cannabis testing facility in the eastern U.S., One year after the United States Department of Agriculture (USDA) issued its final rules on hemp, various states enacted their own regulatory programs. BOCA RATON, Fla.,

Compliance 52

Compliance Compliance Hemp Research and Development 52

Canna Law Blog

JANUARY 3, 2023

Until recently, CBD resided in a legal penumbra where hemp was still scheduled on the federal Controlled Substances Act and could not be cultivated without a permit from the Drug Enforcement Administration (“DEA”). A multitude of states now allow CBD in food and drinks for consumption by humans and animals.

CBD 75

CBD Food Clinical Trials Pets 75

Cannabis Law Report

JULY 28, 2021

The DEA, which enforces the CSA, has indicated that it may consider delta-8 derived from hemp to be a “synthetically derived tetrahydrocannabinol” which still belongs on Schedule I of the CSA. 1, 2022). percent on a dry weight basis.” ” See 7 U.S.C. See 2021 NY S.B. 854, §§90-111. See 2021 NY S.B.

THC 105

THC Hemp CBD Cannabinoids 105

Veriheal

AUGUST 24, 2022

If passed, the Department of Regulatory Agencies would be required to develop rules that would allow for therapeutic psychedelic programs at licensed healing centers for adults to receive psychedelic treatments by a trained facilitator.

Legalization 108

Legalization Medicine Decriminalization Research and Development 108

The Blunt Truth

OCTOBER 8, 2020

Illinois faces another lawsuit over its licensing program. The 9th Circuit may hear a challenge to the DEA’s marijuana scheduling. Commercial sales will begin in 2022. As we’ve reported in the past, Illinois’ cannabis licensing program has had some problems. and finally.

DEA 19

DEA Retail Programs Events 19

Cannabis Law Report

APRIL 21, 2022

MDMA is a promising psychedelic compound, currently placed by the Drug Enforcement Administration (DEA) in Schedule I of the Controlled Substances Act, that has been produced for legal research in small batches by certified laboratories. April 5, 2022.

Clinical Trials 52

Clinical Trials Research and Development Therapy Media 52

Cannabis Law Report

AUGUST 6, 2021

Adjusted EBITDA loss in Q1 2022 was $64 million , a $29 million narrower loss versus Q1 2021 driven by higher sales and lower operating expenses. Adjusted EBITDA loss in Q1 2022 was negatively impacted by a $10.1 First Quarter Fiscal 2022 Financial Summary. (in Highlights. in millions of Canadian. dollars, unaudited).

Vaping 105

Vaping Research and Development Data Business 105

Cannabis Law Report

SEPTEMBER 12, 2022

Virginia 2024 adult use program may be postponed: [link]. DEA grants research license for psychedelics and major depression first human trial: [link]. Dallas County District Attorney discusses freeing up cops for 911 calls instead of 5 hours a piece on marijuana arrest paperwork: [link].

DEA 98

DEA Dispensary Hemp Therapy 98

Cannabis Law Report

JUNE 1, 2021

Remains on track to achieve positive Adjusted EBITDA during the second half of FY 2022. opportunities in Fiscal 2022.” In Q1 2022, Canopy has expanded its portfolio of THC beverages with Tweed Iced Tea beverages (available in lemon and raspberry flavors, both with 5 mg THC) now shipping.

Data 95

Data Vaping Supply Chain Business 95

Project CBD

AUGUST 23, 2023

23 Yet this conversion is occurring without regulatory oversight to ensure process standardization, product specification, and accurate third-party testing, all of which are mandated in state-licensed cannabis programs. 2022) [link] [link] [link] [link] [link] The post Memo to Congress: Fix the Farm Bill appeared first on Project CBD.

Cannabinoids 141

Cannabinoids Hemp THC Safety 141

Cannabis Law Report

APRIL 13, 2022

Apr 12, 2022, 07:00 ET. Transaction expected to close in June 2022 , following anticipated shareholder approval. market presence, complementary client programming and respected clinical research capabilities allow us to accelerate our strategic growth plans and broaden access to healing and wellness.” NEWS PROVIDED BY.

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

SpeedWeed

JULY 17, 2021

Several grant programs would also be established to help provide job training, reentry services, and other benefits for individuals most harmed by the War on Drugs. To fund these programs, the bill would apply a federal sales tax on all legal weed sales.

Legalization 52

Legalization Collective Hash Legislation 52

SpeedWeed

FEBRUARY 24, 2021

Noncompliant hemp used to require its disposal or remediation be conducted by a government official from an agency like the DEA. Hemp must be tested at DEA-registered laboratories, as previous rules state. He said the result left states to make their hemp programs.

Hemp 52

Hemp DEA Research and Development Compliance 52

Kind Meds (Cannabis Education Blog)

FEBRUARY 7, 2022

Review our compilation of cannabis trends for 2022 to stay up to date on the latest news in the cannabis industry and ensure you are prepared for the future. The DEA still classifies cannabis as a Schedule I controlled substance, a designation reserved for drugs with no medical value and a high potential for abuse.

Recreational 52

Recreational Data Cannabis DEA 52

The Cannigma

FEBRUARY 16, 2022

billion made in two years, just two years from January 2020 to January 2022. So, we are partnering with the Harrington Institute to provide two different cohorts here in Chicago, program we have going on. One cohort is specializing in essentially a reentry program. Let’s be clear, it’s not like nothing’s up.

Trichome 73

Trichome Wellness and Beauty Cannabinoids Cannabis 73

The Blunt Truth

JANUARY 19, 2024

HHS DOCUMENT RELEASE Last month , the Department of Health and Human Services (HHS) released a heavily redacted version of their recommendation to the Drug Enforcement Administration (DEA) that cannabis be moved from Schedule I to Schedule III. Of course, the DEA will make its own decision, as we noted earlier this month.

DEA 59

DEA Retail Consumption Legalization 59

The Cannigma

MAY 15, 2023

Schedule III substances are subject to certain controls not applicable to all other prescription drugs, including the requirement that a medical professional with a specific license issued by the Drug Enforcement Agency (DEA) must conduct an in-person examination before prescribing it. At-home ketamine treatment programs vary.

Therapy 78

Therapy Access Blood Pressure Treatment 78

Canna Law Blog

MARCH 7, 2023

EB-5 program. But, there are a few important aspects of Bright Green’s proposal and 2022 EB-5 regulations that, at least in principal, make it more of a wildly risky gambit. The program, known as “EB-5”, is much more complex but for or purposes here that will do. Bright Green Corp., At first blush, that seems patently insane.

DEA 69

DEA Research and Development Programs Cannabis 69

SpeedWeed

APRIL 1, 2021

Fried remembers the debate, featuring a then- High Times editor and a DEA agent, marking the first substantive cannabis conversation during her time at school. . Since 2014, the state has made incremental progress, first legalizing CBD oil, then expanding its medical program in 2016. Florida’s Ongoing Cannabis Reform Efforts.

Agriculture 52

Agriculture Policy THC Cannabis 52

Cannabis Law Report

JUNE 25, 2021

Drug Enforcement Agency (DEA)’s narcotic drug schedule as defined by the Controlled Substances Act (CSA). If it isn’t done before the 2022 election, Republicans could get more seats in both houses, potentially stymieing any progress. Cannabidiol (CBD) products derived from industrial hemp exist in a unique market here in the U.S.

Banking 66

Banking CBD Hemp Seed-To-Sale 66

Cannabis Law Report

AUGUST 5, 2021

Schumer’s proposal (keep in mind that he is up for reelection in 2022) includes five key pillars: Federally deschedule cannabis- The Attorney General would have 60 days to formalize this and treat cannabis as a dietary supplement with the ability to make claims like other supplements. Key Elements of Proposal. Still Unresolved.

Banking 111

Banking Vaping Education DEA 111

Cannabis Law Report

JUNE 27, 2022

The Drug Enforcement Administration (DEA) said in a letter that marijuana seed that has a delta-9-THC concentration of not more than 0.3% million in the first month following launch of the program. [link]. Spain approves medical cannabis reform, pharmacy dispensing planned for end of 2022: [link]. INDUSTRY NEWS. Cannabinoids.

Seed-To-Sale 52

Seed-To-Sale Hemp Retail Treatment 52

The Blunt Truth

DECEMBER 31, 2020

Senator Mitch McConnell (R-KY) objected to including cannabis banking in federal relief programs. The DEA released an interim hemp rule that the industry hated. And the DEA’s hemp rule brought on litigation. And the DEA’s hemp rule brought on litigation. The DEA hemp rule continued its unpopularity.

DEA 109

DEA Decriminalization Hemp Banking 109